다음과같은구성요소를모두갖추어야한다. 1. 학술지기본구성요소 표 30. 학술지구성요소 대분류중분류항목 앞부분 (Front matter) 1) 표지 (Front cover) 2) 판권란 (Masthead) pissn eissn Official title Homepage URL address Publisher pissn ( 인쇄본이없는경우생략 ) eissn Journal title (official title) Aims and scope ( 목적과범위 ) Official abbreviated title by ISO/PubMed Year of launching of journal Frequency Circulation number of journal print copies ( 호당발행부수 ) Availability of the full text in the web Databases indexed/covered/cited Any fund supports Subscription information Copyright statement Creative Commons License statement (open access 인경우기술 ) Publisher Printing company Contact information: Address, Telephone, FAX, email, URL address of homepage Permanence of paper/acid free paper 33
논문부분 (Article part) 3) 책등 (Book spine) 4) 목차 (Table of content) 1) 제목부분 (Title page) 2) 본문 (Main text) 3) 논문뒷부분 (Article back matters) Editorial board: Editor, Associate editor(s), Editorial board members, Ethics editor, Statistical editor, Manuscript editor, Lay-out editor, homepage and XML producing engineer Journal title Year Month Volume Issue Page Publisher pissn ( 인쇄본이없는경우생략 ) eissn Journal title Subheading for type: Editorial, Opinion, Review, Original article, Brief note, Case report, Teaching material/cme, Book review, Letter to the editor, Errata/Revision/Retraction, Announcement Page Article title Copyright statement Bibliographic information Digital object identifier (DOI) Title/Author/Affiliation Abstract/Keyword Date of received, revised, and accepted ( 또는 Date of accepted, accepted, and published) Corresponding author s contact information Copyright statement pissn ( 인쇄본이없는경우생략 ), eissn Other notes: present address, presentation place and date Introduction Methods Results Discussion Tables Figures ORCID Author taxonomy ( 저자역할구분도입하는경우 ) Conflict of interest Funding Acknowledgments References Appendixes Additional supplementary materials such as raw data, audio-video materials etc. 34
뒷부분 (Journal back matters) 1) 투고규정 (Information for authors) General information Research and ethics Manuscript preparation Manuscript submission Article processing charge Peer review and process Copyrights, open access policy, and open data policy Contact information 2) 기타뒷부분 Best practice Policies Author check list Author s agreement of originality and statement of copyright transfer Conflict of interest disclosure Back cover 2. 학술지누리집구성요소아래와같은내용을영문누리집에서최소한으로반드시갖추어야하고물론이외도앞에기술한구성요소를다보여주고, digital standard를전부구현하는것이필요하다. 표 31. 학술지영문누리집에서제공할최소내용목록번호항목 1 Aims and scope 2 Editorial board 3 Current issue 4 Archiving (back issue) 5 Instructions to authors 6 Research and ethics 7 Copyright policy and license 8 Article processing charge or submission fee 9 Subscription information 10 Contact information 11 Manuscript management system 3. 단위표기학술지에서는국제표준측정단위를사용한다. 표 32. 과학논문에서사용하는 SI 표기 ( 출처 : https://www.iso.org/standard/30669.html) Name Symbol Quantity metre m length 길이 kilogram kg mass 무게 35
second s time 시간 ampere A electric current 전류 kelvin K thermodynamic temperature 열역학온도 mole mol amount of substance 질량 candela cd luminous intensity 조도 4. 보존용지 (Permanence of paper) 인쇄본을발행할경우사용하는용지의특성을기술하여야한다. 보존성이우수한기록재료를 보존용지라고하는데이규격의조건은표준설정기관에따라약간차이가있으며다음과같다. 표 33. ANSI Z39.48-1992 보존용지규격 ( 출처 : https://groups.niso.org/apps/group_public/download. php/13464/z39-48-1992_r2009.pdf) 항목 종류 기준 단일종류 ph 7.5-10 ( 냉수추출법 ) 펄프의종류화학펄프 100% 탄산칼슘함량 인열강도 (Tear resistance) Kappa 값 2% 이상 최소 5.25 mnm 2 /g ( 코팅하지않은경우 ) 최소 3.50 mnm 2 /g ( 코팅한경우 ) 7.0 미만 표 34. ISO 9706-1994 보존용지규격 ( 출처 : https://www.iso.org/standard/17562.html) 항목 설명 종류 단일종류 ph 7.5-10 ( 냉수추출법 ) 펄프의종류 화학펄프 100% 탄산칼슘함량 2% 이상 인열강도 최소 5 mnm 2 /g ( 코팅여부와무관 ) Kappa 값 5.0 미만 측정항목중탄산칼슘은알칼리함량을뜻하고 Kappa 값은리그닌 (lignin, 목재, 대나무, 짚따위의목화 ( 木化 ) 한식물체속에 20-30% 존재하는방향족고분자화합물 ) 함량을뜻한다. 리그닌함량이많으면시간이지날수록누렇게변하는것을관찰할수있다. 인열강도 (tear index) 는잡아당겨찢어트리는데드는힘을뜻한다. 국내에서학술지에많이사용하는일부종이를대상으로측정한결과한솔제지의밀레니움아트지가위조건을충족하여많은학술지가재질을바꾸었다. 국내많은제지사가자기회사가생산하는종이가 KS, ISO ANSI/NISO 규격에따른보존용지인지아닌지를어디에도소비자가쉽게알수있도록구체적으로표기하지않고판매하고있어, 중간유통단계의제업사도내용을모르는경우가많다. 그러므로사용자가측정을의뢰하는 36
등의작업을통해정보를습득하여야한다. 예를들면어느종이를사용하는학회에서그종이가보존용지인지알려면제업사또는생산회사에우선문의하여보고정보를구할수없으면직접국내에서측정기관에의뢰하여야한다. 국내에서는서울대학교농업생명과학대학산림과학부환경재료과학전공, 제지공학및종이물성학연구실에측정의뢰를부탁할수있으나측정및결과제공여부는연구실운영사정에따른다. 그리고이런보존용지를사용할때는다음과같이표기하는것이필요하다. This paper meets the requirements of ANSI/NISO Z39.48-1992 (Permanence of Paper). 또는 This paper meets the requirements of ISO 9706-1994 and ANSI/NISO Z39.48-1992 (Permanence of Paper). 이보존용지기술이왜필요할까? 이런기술이있는지여부에따라서도서관에서학술지보관장소가달라지기때문이다. 과거산성종이에인쇄한것은별도의보관장소가있다. 그러므로편집인은학술지의종이가보존용지인지아닌지알수없다면최소다음과같이알칼리종이에인쇄한다고표기하여야한다. 우리나라에서학술지인쇄를위하여유통하는대부분의종이는모두알칼리종이이므로따로검사를받지않고아래처럼표기하여도무방하다. It is printed on acid-free paper. 이렇게표기하는것이학술지의종이질에대한최소수준을알려주는정보로필요하다. 37
5. 라이선스유형 표 35. 크리에이티브커먼즈라이선스유형 ( 출처 : https://creativecommons.org/licenses/) 학술지를 open access 로발행한다고선언하려면반드시크리에이티브커먼즈라이선스를기술하여야하며여러유형은아래와같은데이가운데한종을선택하여기술한다. CC BY CC BY-NC CC BY-NC-ND CC BY-NC-SA CC BY-ND CC BY-SA 상업적활용도가능 비상업적목적일경우에한해활용허락 저작물을다운로드하고공유하는것만허용되며, 어떠한변경도가할수없고상업적으로이용할수도없음 2 차적저작물에도동일한라이선스를적용하는한, 저작물을비상업적용도로활용허락 저작물이수정, 편집되지않은상태로제공되는한상업적, 비상업적목적의재배포를모두허락 2 차저작물에도상업적이용가능 6. Clinical data sharing policy ICMJE 출판원칙을따르는학술지인경우임상자료를다룰때어느범위까지공개할지를저자 ( 연구자, 투고자 ) 가정하도록하고있다. 이정책은강제조항이아니고저자가선택할수있는것이고이것을선언하라는것이므로바로적용하여도원고받는데아무지장이없다. 표 36. Clinical data statement 에서저자가선택하는공개범위예 ( 출처 : http://www.icmje.org/ recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html#two) What data Example 1 Example 2 Example 3 Example 4 All of the de-identified individual patient data collected during the trial With whom Anyone who wishes to access the data Start date Immediately following. De-identified individual patient data that underlie the results reported in this article (text, tables, figures, and appendices) Researchers who provide a methodologically sound proposal 3 months following article End date No end date 5 years following article For what purpose Mechanism to obtain Any purpose Data are available indefinitely at (Link to be included). To achieve aims in the approved proposal Proposals should be directed to xxx@yyy. To gain access, data requestors will need to sign a data access agreement. Data are available for x years at a third party website. (Link to be included) De-identified individual patient data that underlie the results reported in this article (text, tables, figures, and appendices) Investigators whose proposed use of the data has been approved by an independent review committee ( learned intermediary ) identified for this purpose 9 months following article 36 months following article For individual patient data meta-analysis Up to 36 months following article, submit proposals at (Link to be included). After 36 months the data will be available in our University s data warehouse. (Link to be included) Not available Trial participants have not consented for their individual data to be shared 38